144 related articles for article (PubMed ID: 21145177)
1. Comparison of the platelet concentrations obtained in platelet-rich plasma (PRP) between the GPS™ II and GPS™ III systems.
Kaux JF; Le Goff C; Renouf J; Peters P; Lutteri L; Gothot A; Crielaard JM
Pathol Biol (Paris); 2011 Oct; 59(5):275-7. PubMed ID: 21145177
[TBL] [Abstract][Full Text] [Related]
2. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma.
Sundman EA; Cole BJ; Fortier LA
Am J Sports Med; 2011 Oct; 39(10):2135-40. PubMed ID: 21846925
[TBL] [Abstract][Full Text] [Related]
3. Platelet-rich plasma preparation using three devices: implications for platelet activation and platelet growth factor release.
Everts PA; Brown Mahoney C; Hoffmann JJ; Schönberger JP; Box HA; van Zundert A; Knape JT
Growth Factors; 2006 Sep; 24(3):165-71. PubMed ID: 17079200
[TBL] [Abstract][Full Text] [Related]
4. Effects of platelet-rich plasma on intestinal anastomotic healing in rats: PRP concentration is a key factor.
Yamaguchi R; Terashima H; Yoneyama S; Tadano S; Ohkohchi N
J Surg Res; 2012 Apr; 173(2):258-66. PubMed ID: 21074782
[TBL] [Abstract][Full Text] [Related]
5. Autologous concentrated platelet-rich plasma (cPRP) for local application in bone regeneration.
Dugrillon A; Eichler H; Kern S; Klüter H
Int J Oral Maxillofac Surg; 2002 Dec; 31(6):615-9. PubMed ID: 12521317
[TBL] [Abstract][Full Text] [Related]
6. Concentration of platelets and growth factors in canine autologous conditioned plasma.
Stief M; Gottschalk J; Ionita JC; Einspanier A; Oechtering G; Böttcher P
Vet Comp Orthop Traumatol; 2011; 24(2):122-5. PubMed ID: 21225088
[TBL] [Abstract][Full Text] [Related]
7. Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomised trial of autologous blood injections versus platelet-rich plasma injections.
Creaney L; Wallace A; Curtis M; Connell D
Br J Sports Med; 2011 Sep; 45(12):966-71. PubMed ID: 21406450
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of five techniques of preparation of platelet-rich plasma].
Kaux JF; Le Goff C; Seidel L; Péters P; Gothot A; Albert A; Crielaard JM
Pathol Biol (Paris); 2011 Jun; 59(3):157-60. PubMed ID: 19481375
[TBL] [Abstract][Full Text] [Related]
9. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: a review of the literature.
Alsousou J; Thompson M; Hulley P; Noble A; Willett K
J Bone Joint Surg Br; 2009 Aug; 91(8):987-96. PubMed ID: 19651823
[TBL] [Abstract][Full Text] [Related]
10. [Effect of autologous platelet-rich plasma (PRP) in cardiac surgery].
Okamura T; Koh E; Yokoyama S
Kyobu Geka; 2001 May; 54(5):397-400. PubMed ID: 11357304
[TBL] [Abstract][Full Text] [Related]
11. Platelet rich placebo? Evidence for platelet rich plasma in the treatment of tendinopathy and augmentation of tendon repair.
Hall MP; Ward JP; Cardone DA
Bull Hosp Jt Dis (2013); 2013; 71(1):54-9. PubMed ID: 24032584
[TBL] [Abstract][Full Text] [Related]
12. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF).
Dohan Ehrenfest DM; Rasmusson L; Albrektsson T
Trends Biotechnol; 2009 Mar; 27(3):158-67. PubMed ID: 19187989
[TBL] [Abstract][Full Text] [Related]
13. Correlation of platelet concentration in platelet-rich plasma to the extraction method, age, sex, and platelet count of the donor.
Weibrich G; Kleis WK; Kunz-Kostomanolakis M; Loos AH; Wagner W
Int J Oral Maxillofac Implants; 2001; 16(5):693-9. PubMed ID: 11669252
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of factors that can modify platelet-rich plasma properties.
Andrade MG; de Freitas Brandão CJ; Sá CN; de Bittencourt TC; Sadigursky M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jan; 105(1):e5-e12. PubMed ID: 18155603
[TBL] [Abstract][Full Text] [Related]
15. Platelet-rich plasma products in sports medicine.
Bava ED; Barber FA
Phys Sportsmed; 2011 Sep; 39(3):94-9. PubMed ID: 22030945
[TBL] [Abstract][Full Text] [Related]
16. Avoiding leukocyte contamination and early platelet activation in platelet-rich plasma.
Trindade-Suedam IK; Leite FR; de Morais JA; Leite ER; Marcantonio EJ; Leite AA
J Oral Implantol; 2007; 33(6):334-9. PubMed ID: 18240792
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of postoperative drainage with application of platelet-rich and platelet-poor plasma following hemithyroidectomy: a randomized controlled clinical trial.
Yoo J; Roth K; Hughes B; Fung K; Franklin J; Lampe H; Pietrzak WS
Head Neck; 2008 Dec; 30(12):1552-8. PubMed ID: 18704963
[TBL] [Abstract][Full Text] [Related]
18. Platelet rich plasma. The use of autologous growth factors to enhance bone and soft tissue grafts.
Tischler M
N Y State Dent J; 2002 Mar; 68(3):22-4. PubMed ID: 11989332
[TBL] [Abstract][Full Text] [Related]
19. Preliminary separation of the growth factors in platelet-rich plasma: effects on the proliferation of human marrow-derived mesenchymal stem cells.
Huang Q; Wang YD; Wu T; Jiang S; Hu YL; Pei GX
Chin Med J (Engl); 2009 Jan; 122(1):83-7. PubMed ID: 19187622
[TBL] [Abstract][Full Text] [Related]
20. [Preparation of autologous platelet-rich gel for diabetic refractory dermal ulcer and growth factors analysis from it].
Yuan N; Wang C; Wang Y; Yu T; Long Y; Zhang X; Ran X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Apr; 22(4):468-71. PubMed ID: 18575451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
